BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Infectio Diagnostic Inc. Signs Partnership Agreement With bioMerieux, Inc. World Leader In Clinical Microbiology


10/19/2005 5:10:01 PM

QUEBEC CITY, Feb. 16 /PRNewswire/ -- Following on its agreement with Chiron Corporation of Emeryville, California, Infectio Diagnostic Inc. (IDI) of Quebec City has entered into partnership with bioMerieux, a world leader in clinical microbiology.

The agreement specifically stipulates that bioMerieux will receive a licence providing access to part of IDI's intellectual property in the area of identification and bacterial-resistance markers.

According to IDI President, Jean-Pierre Gayral, "This agreement has brought our company to where we can achieve our primary objective - to make IDI a world leader in clinical microbiology - and confirms the value of the technology developed by IDI and the researchers of the Centre de recherche en infectiologie (Infectiology Research Centre) of Universite Laval.

With 5,500 employees globally, bioMerieux is the world's eighth largest biological diagnostics corporation.

This agreement with bioMerieux and the one signed recently with Chiron Corporation will result in the creation of more research and development jobs at IDI's Quebec City facilities.

INFECTIO DIAGNOSTIC INC.

CONTACT: Jacques Milette, Vice President, Marketing and BusinessDevelopment, (418) 681-4343, extension 246, Cellphone:(418) 262-3816


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->